A pharmaceutically manufactured cannabidiol (CBD) formulation has a good overall safety profile with no cardiac safety concerns, reported a new study recently presented at Heart Failure 2025, a scientific…
A pharmaceutically manufactured cannabidiol (CBD) formulation has a good overall safety profile with no cardiac safety concerns, reported a new study recently presented at Heart Failure 2025, a scientific…